Bio-Rad Laboratories (BIO) Stock Research

Bio-Rad Laboratories

· BIO

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

10.185 B

-0.48%

Thursday

Biodesix advances two programs for Molecular Residual Disease monitoring

Sep 24, 6:13 AM

Over a week ago

Bio-Rad price target raised by $20 at RBC Capital

Aug 7, 8:06 AM

Bio-Rad price target raised by $50 at RBC Capital, here's why

Aug 5, 7:34 AM

Bio-Rad price target raised by $30 at Citi

Aug 5, 6:31 AM

Bio-Rad inititates restructuring plan, to cut jobs

Aug 4, 4:48 PM

Bio-Rad backs FY26 revenue growth view (3%)-0.5%

Aug 4, 4:26 PM

Bio-Rad reports Q2 adjusted EPS $2.62, consensus $1.75

Aug 4, 4:25 PM

Bio-Rad slips as Sartorius weighed on by Danaher bioprocessing unit miss

Jul 21, 10:12 AM

Bio-Rad price target raised by $20 at Wells Fargo, here's why

May 25, 5:06 AM

Bio-Rad rises 11.6%

May 18, 12:02 PM

Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp

+28

May 18, 12:00 PM

Bio-Rad rises 10.5%

May 18, 10:00 AM

Video: NextEra buying Dominion to form energy giant

May 18, 9:05 AM

Morning Movers: LiveRamp jumps following pact to be acquired by Publicis

+11

May 18, 9:01 AM

Fly Intel: Top five weekend stock stories

May 17, 9:14 PM

Activist investor Elliot builds big stake in Bio-Rad, WSJ says

May 17, 9:00 PM

Bio-Rad resumed with an Outperform at RBC Capital

May 14, 4:24 PM

Bio-Rad price target lowered by $30 at Wells Fargo, here's why

May 1, 6:27 AM

Bio-Rad reports Q1 EPS $1.89, consensus $1.99

Apr 30, 4:25 PM

Bio-Rad just downgraded at Citi, here's why

Apr 7, 6:06 AM

Citi gets more bearish on Bio-Rad, downgrades shares

Apr 7, 5:39 AM

Bio-Rad price target lowered by $20 at Wells Fargo, here's why

Feb 16, 7:43 AM

Bio-Rad price target lowered by $15 at UBS, here's why

Feb 13, 9:33 AM

Bio-Rad sees FY26 currency neutral revenue growth 0.5%-1.5%

Feb 12, 4:18 PM

Bio-Rad reports Q4 adjusted EPS $2.51, consensus $2.70

Feb 12, 4:18 PM

Charts

Thursday

Biodesix advances two programs for Molecular Residual Disease monitoring

Sep 24, 6:13 AM

Over a week ago

Bio-Rad price target raised by $20 at RBC Capital

Aug 7, 8:06 AM

Bio-Rad price target raised by $50 at RBC Capital, here's why

Aug 5, 7:34 AM

Bio-Rad price target raised by $30 at Citi

Aug 5, 6:31 AM

Bio-Rad inititates restructuring plan, to cut jobs

Aug 4, 4:48 PM

Bio-Rad backs FY26 revenue growth view (3%)-0.5%

Aug 4, 4:26 PM

Bio-Rad reports Q2 adjusted EPS $2.62, consensus $1.75

Aug 4, 4:25 PM

Bio-Rad slips as Sartorius weighed on by Danaher bioprocessing unit miss

Jul 21, 10:12 AM

Bio-Rad price target raised by $20 at Wells Fargo, here's why

May 25, 5:06 AM

Bio-Rad rises 11.6%

May 18, 12:02 PM

Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp

+28

May 18, 12:00 PM

Bio-Rad rises 10.5%

May 18, 10:00 AM

Video: NextEra buying Dominion to form energy giant

May 18, 9:05 AM

Morning Movers: LiveRamp jumps following pact to be acquired by Publicis

+11

May 18, 9:01 AM

Fly Intel: Top five weekend stock stories

May 17, 9:14 PM

Activist investor Elliot builds big stake in Bio-Rad, WSJ says

May 17, 9:00 PM

Bio-Rad resumed with an Outperform at RBC Capital

May 14, 4:24 PM

Bio-Rad price target lowered by $30 at Wells Fargo, here's why

May 1, 6:27 AM

Bio-Rad reports Q1 EPS $1.89, consensus $1.99

Apr 30, 4:25 PM

Bio-Rad just downgraded at Citi, here's why

Apr 7, 6:06 AM

Citi gets more bearish on Bio-Rad, downgrades shares

Apr 7, 5:39 AM

Bio-Rad price target lowered by $20 at Wells Fargo, here's why

Feb 16, 7:43 AM

Bio-Rad price target lowered by $15 at UBS, here's why

Feb 13, 9:33 AM

Bio-Rad sees FY26 currency neutral revenue growth 0.5%-1.5%

Feb 12, 4:18 PM

Bio-Rad reports Q4 adjusted EPS $2.51, consensus $2.70

Feb 12, 4:18 PM

Company News

Charts